{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T20:45:19Z","timestamp":1794948319296,"version":"4.9.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T00:00:00Z","timestamp":1686096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T00:00:00Z","timestamp":1686096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinik M\u00fcnchen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>As a high-quality TUR-BT is important to ensure adequate treatment for bladder cancer patients, the aim of the current study is to investigate the impact of patient-related, surgical and tumor-specific parameters on detrusor muscle (DM) absence (primary objective) and to assess the impact of DM on the prognosis after a TUR-BT (secondary objective).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and methods<\/jats:title>\n                    <jats:p>\n                      Transurethral resection of bladder tumors (TUR-BTs) between 2009 and 2021 were retrospectively screened (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20093237). We included 2058 cases (1472 patients) for the primary and 472 patients for secondary objective. Clinicopathological variables including tumor size, localization, multifocality, configuration, operation time and skill-level of the urologist were assessed. We analyzed predictors for missing DM and prognostic factors for recurrence-free survival (RFS) for the complete cohort and subgroups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      DM was present in 67.6% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091371\/2058). Surgery duration (continuous, minutes) was an independent predictor for absence of DM in the complete cohort (OR:0.98, r:0.012, 95%CI:0.98\u20130.99,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001). Other significant risk factors for missing DM were papillary tumors (OR:1.99, r:0.251, 95%CI:1.22\u20133.27,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.006) in the complete cohort and bladder-roof and posterior-bladder-wall localization for re-resections. Absence of DM in high-grade BC correlated with reduced RFS (HR:1.96, 95%CI:1.0\u20133.79,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.045).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Sufficient time for a TUR-BT is mandatory to assure DM in the TUR-BT specimen. Also, cases with more difficult locations of bladder tumors should be performed with utmost surgical diligence and endourological training should incorporate how to perform such operations. Of note, DM correlates with improved oncological prognosis in high-grade BC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12894-023-01278-7","type":"journal-article","created":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T12:01:52Z","timestamp":1686139312000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Absence of detrusor muscle in TUR-BT specimen \u2013 can we predict who is at highest risk?"],"prefix":"10.1186","volume":"23","author":[{"given":"Yannic","family":"Volz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabea","family":"Trappmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Ebner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennert","family":"Eismann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Pyrgidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo","family":"Pfitzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Bischoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Schlenker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Stief","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald Bastian","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,7]]},"reference":[{"issue":"1","key":"1278_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","volume":"81","author":"M Babjuk","year":"2022","unstructured":"Babjuk M, et al. European association of urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and Carcinoma in Situ). Eur Urol. 2022;81(1):75\u201394.","journal-title":"Eur Urol"},{"issue":"6","key":"1278_CR2","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1016\/j.juro.2014.01.087","volume":"191","author":"KA Richards","year":"2014","unstructured":"Richards KA, Smith ND, Steinberg GD. The importance of transurethral resection of bladder tumor in the management of nonmuscle invasive bladder cancer: a systematic review of novel technologies. J Urol. 2014;191(6):1655\u201364.","journal-title":"J Urol"},{"issue":"1","key":"1278_CR3","doi-asserted-by":"publisher","first-page":"40.e17","DOI":"10.1016\/j.urolonc.2013.04.009","volume":"32","author":"O Shoshany","year":"2014","unstructured":"Shoshany O, et al. Presence of detrusor muscle in bladder tumor specimens\u2013predictors and effect on outcome as a measure of resection quality. Urol Oncol. 2014;32(1):40.e17-22.","journal-title":"Urol Oncol"},{"issue":"4","key":"1278_CR4","doi-asserted-by":"publisher","first-page":"e784","DOI":"10.1016\/j.clgc.2019.04.014","volume":"17","author":"M Akand","year":"2019","unstructured":"Akand M, et al. Quality control indicators for transurethral resection of non-muscle-invasive bladder cancer. Clin Genitourin Cancer. 2019;17(4):e784\u201392.","journal-title":"Clin Genitourin Cancer"},{"issue":"11","key":"1278_CR5","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1111\/j.1464-410X.2011.10571.x","volume":"109","author":"P Mariappan","year":"2012","unstructured":"Mariappan P, et al. Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking. BJU Int. 2012;109(11):1666\u201373.","journal-title":"BJU Int"},{"issue":"2","key":"1278_CR6","first-page":"170","volume":"69","author":"A Rolevich","year":"2016","unstructured":"Rolevich A, et al. Surgeon has a major impact on long-term recurrence risk in patients with non-muscle invasive bladder cancer. Cent European J Urol. 2016;69(2):170\u20137.","journal-title":"Cent European J Urol"},{"issue":"6","key":"1278_CR7","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.eururo.2016.12.020","volume":"71","author":"NJ Giacalone","year":"2017","unstructured":"Giacalone NJ, et al. Long-term outcomes after bladder-preserving tri-modality therapy for patients with muscle-invasive bladder cancer: an updated analysis of the massachusetts general hospital experience. Eur Urol. 2017;71(6):952\u201360.","journal-title":"Eur Urol"},{"issue":"5","key":"1278_CR8","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.eururo.2009.05.047","volume":"57","author":"P Mariappan","year":"2010","unstructured":"Mariappan P, Zachou A, Grigor KM. Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience. Eur Urol. 2010;57(5):843\u20139.","journal-title":"Eur Urol"},{"issue":"5","key":"1278_CR9","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1007\/s00345-013-1205-1","volume":"32","author":"T Shindo","year":"2014","unstructured":"Shindo T, et al. Clinical significance of definite muscle layer in TUR specimen for evaluating progression rate in T1G3 bladder cancer: multicenter retrospective study by the Sapporo Medical University Urologic Oncology Consortium (SUOC). World J Urol. 2014;32(5):1281\u20135.","journal-title":"World J Urol"},{"key":"1278_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2022.103577","volume":"170","author":"F Crocetto","year":"2022","unstructured":"Crocetto F, et al. Liquid biopsy in bladder cancer: State of the art and future perspectives. Crit Rev Oncol Hematol. 2022;170: 103577.","journal-title":"Crit Rev Oncol Hematol"},{"key":"1278_CR11","doi-asserted-by":"crossref","unstructured":"Ferro, M., et al., Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy. Future Science OA, 2021. 7(7): p. FSO709.","DOI":"10.2144\/fsoa-2021-0008"},{"issue":"1","key":"1278_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.eururo.2019.09.001","volume":"78","author":"JJ Leow","year":"2020","unstructured":"Leow JJ, et al. Quality indicators for bladder cancer services: a collaborative review. Eur Urol. 2020;78(1):43\u201359.","journal-title":"Eur Urol"},{"issue":"1","key":"1278_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/bju.13354","volume":"118","author":"P Gontero","year":"2016","unstructured":"Gontero P, et al. The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade\/Grade 3 bladder cancer treated with bacille Calmette-Gu\u00e9rin. BJU Int. 2016;118(1):44\u201352.","journal-title":"BJU Int"},{"issue":"4","key":"1278_CR14","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.eururo.2020.06.051","volume":"78","author":"P Mariappan","year":"2020","unstructured":"Mariappan P, et al. Enhanced quality and effectiveness of transurethral resection of bladder tumour in non-muscle-invasive bladder cancer: a multicentre real-world experience from scotland\u2019s quality performance indicators programme. Eur Urol. 2020;78(4):520\u201330.","journal-title":"Eur Urol"},{"issue":"4","key":"1278_CR15","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.juro.2016.03.151","volume":"196","author":"C Anderson","year":"2016","unstructured":"Anderson C, et al. A 10-Item checklist improves reporting of critical procedural elements during transurethral resection of bladder tumor. J Urol. 2016;196(4):1014\u201320.","journal-title":"J Urol"},{"issue":"7","key":"1278_CR16","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/iju.14548","volume":"28","author":"R Taoka","year":"2021","unstructured":"Taoka R, et al. Use of surgical checklist during transurethral resection increases detrusor muscle collection rate and improves recurrence-free survival in patients with non-muscle-invasive bladder cancer. Int J Urol. 2021;28(7):727\u201332.","journal-title":"Int J Urol"},{"issue":"3","key":"1278_CR17","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1097\/JU.0000000000001372","volume":"205","author":"A Das","year":"2021","unstructured":"Das A, et al. Surgeon scorecards improve muscle sampling on transurethral resection of bladder tumor and recurrence outcomes in patients with nonmuscle invasive bladder cancer. J Urol. 2021;205(3):693\u2013700.","journal-title":"J Urol"},{"issue":"3","key":"1278_CR18","doi-asserted-by":"publisher","first-page":"275","DOI":"10.4103\/0970-1591.102700","volume":"28","author":"R Upadhyay","year":"2012","unstructured":"Upadhyay R, et al. Does En-bloc transurethral resection of bladder tumor give a better yield in terms of presence of detrusor muscle in the biopsy specimen? Indian J Urol. 2012;28(3):275\u20139.","journal-title":"Indian J Urol"},{"issue":"9","key":"1278_CR19","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/nrurol.2016.147","volume":"13","author":"A Aydin","year":"2016","unstructured":"Aydin A, et al. Simulation-based training and assessment in urological surgery. Nat Rev Urol. 2016;13(9):503\u201319.","journal-title":"Nat Rev Urol"},{"issue":"5","key":"1278_CR20","first-page":"6459","volume":"19","author":"M Roupr\u00eat","year":"2012","unstructured":"Roupr\u00eat M, et al. The presence of detrusor muscle in the pathological specimen after transurethral resection of primary pT1 bladder tumors and its relationship to operator experience. Can J Urol. 2012;19(5):6459\u201364.","journal-title":"Can J Urol"},{"key":"1278_CR21","doi-asserted-by":"crossref","unstructured":"Herr, H.W. and S.M. Donat, Quality control in transurethral resection of bladder tumours. BJU Int, 2008. 102(9 Pt B): p. 1242\u20136.","DOI":"10.1111\/j.1464-410X.2008.07966.x"},{"issue":"4","key":"1278_CR22","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1089\/end.2015.0591","volume":"30","author":"P Capogrosso","year":"2016","unstructured":"Capogrosso P, et al. Detrusor muscle in TUR-derived bladder tumor specimens: can we actually improve the surgical quality? J Endourol. 2016;30(4):400\u20135.","journal-title":"J Endourol"},{"issue":"2","key":"1278_CR23","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.urology.2015.04.015","volume":"86","author":"P Mariappan","year":"2015","unstructured":"Mariappan P, et al. Real-life experience: early recurrence with hexvix photodynamic diagnosis-assisted transurethral resection of bladder tumour vs good-quality white light TURBT in new non-muscle-invasive bladder cancer. Urology. 2015;86(2):327\u201331.","journal-title":"Urology"},{"issue":"6","key":"1278_CR24","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1053\/hupa.2001.24999","volume":"32","author":"SJ Cina","year":"2001","unstructured":"Cina SJ, et al. Correlation of cystoscopic impression with histologic diagnosis of biopsy specimens of the bladder. Hum Pathol. 2001;32(6):630\u20137.","journal-title":"Hum Pathol"},{"issue":"8","key":"1278_CR25","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1308\/rcsann.2016.0246","volume":"98","author":"VA During","year":"2016","unstructured":"During VA, et al. Prediction of histological stage based on cystoscopic appearances of newly diagnosed bladder tumours. Ann R Coll Surg Engl. 2016;98(8):547\u201351.","journal-title":"Ann R Coll Surg Engl"},{"key":"1278_CR26","unstructured":"Haeuser, L., et al., Association between Operative Time and Short-Term Radical Cystectomy Complications. Urol Int, 2022: p. 1\u20137."},{"issue":"6","key":"1278_CR27","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1097\/JU.0000000000001633","volume":"205","author":"JT Matulay","year":"2021","unstructured":"Matulay JT, et al. Contemporary outcomes of patients with nonmuscle-invasive bladder cancer treated with bacillus calmette-guerin: implications for clinical trial design. J Urol. 2021;205(6):1612\u201321.","journal-title":"J Urol"},{"issue":"6","key":"1278_CR28","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.euf.2020.08.007","volume":"7","author":"R Mastroianni","year":"2021","unstructured":"Mastroianni R, et al. Assessing the impact of the absence of detrusor muscle in ta low-grade urothelial carcinoma of the bladder on recurrence-free survival. Eur Urol Focus. 2021;7(6):1324\u201331.","journal-title":"Eur Urol Focus"},{"issue":"5","key":"1278_CR29","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1245\/s10434-016-5700-7","volume":"24","author":"JY Teoh","year":"2017","unstructured":"Teoh JY, et al. Comparison of detrusor muscle sampling rate in monopolar and bipolar transurethral resection of bladder tumor: a randomized trial. Ann Surg Oncol. 2017;24(5):1428\u201334.","journal-title":"Ann Surg Oncol"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-023-01278-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-023-01278-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-023-01278-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:02:35Z","timestamp":1686182555000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-023-01278-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,7]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1278"],"URL":"https:\/\/doi.org\/10.1186\/s12894-023-01278-7","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,7]]},"assertion":[{"value":"21 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained by the local ethical committee board of the Ludwig-Maximilian-University (No.: 20\u20131090), all methods were carried out in accordance with relevant guidelines and regulation. The need for written informed consent was waived by the Ludwig-Maximilian-University ethics committee due to retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"The authors declare no competing interests.\u00a0","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"106"}}